BIOLASE, Inc. (NASDAQ:BIOL) Short Interest Down 74.1% in April

BIOLASE, Inc. (NASDAQ:BIOL) was the recipient of a large drop in short interest during the month of April. As of April 15th, there was short interest totalling 592,700 shares, a drop of 74.1% from the March 31st total of 2,290,000 shares. Currently, 1.9% of the shares of the company are short sold. Based on an average daily trading volume, of 5,510,000 shares, the short-interest ratio is currently 0.1 days.

BIOLASE Price Performance

BIOLASE stock traded up $0.00 during trading on Friday, reaching $0.15. The company had a trading volume of 663,098 shares, compared to its average volume of 4,451,342. BIOLASE has a 52 week low of $0.13 and a 52 week high of $32.09. The firm’s 50-day simple moving average is $0.15 and its 200 day simple moving average is $0.83. The company has a debt-to-equity ratio of 34.06, a current ratio of 1.26 and a quick ratio of 0.68.

BIOLASE (NASDAQ:BIOL) last announced its earnings results on Thursday, March 21st. The medical technology company reported ($1.76) EPS for the quarter. BIOLASE had a negative return on equity of 555.22% and a negative net margin of 41.97%. The company had revenue of $13.49 million during the quarter.

Analyst Upgrades and Downgrades

Separately, StockNews.com started coverage on BIOLASE in a report on Friday. They issued a “sell” rating on the stock.

About BIOLASE

BIOLASE, Inc, together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications.